AGBL2 and rheumatoid arthritis: Investigators have shown that IgM anti-CCP2 antibodies are present in both early and established disease [8] and one later study showed that IgA and IgM anti-CCP2 antibodies were present in RA and were similarly specific for RA as IgG anti-CCP2 antibodies [9].